To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BCL7CTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
132 supporting clones for gene BCL7C back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BY795330 eye .a 1 to 556 1 to 556   tiling clone,   556/556
(100 %)
0 diff
(100 %id)
CR977876 T-Lymphocytes .a 60 to 487 1 to 428       428/437
(97 %)
2 diff
(99.6 %id)
BC058863 Brain, adult medulla .a 74 to 2056 1 to 1983   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1983/1983
(100 %)
2 diff
(99.9 %id)
CN290981 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 187 to 363 1 to 177       177/177
(100 %)
2 diff
(98.9 %id)
BQ440288 leiomyosarcoma, uterus .a 192 to 822 1 to 638       638/922
(69 %)
21 diff
(97.8 %id)
BU159087 large cell carcinoma, lung .a 210 to 776 1 to 573       573/1105
(51 %)
36 diff
(96.8 %id)
BU595499 mixed (pool of 40 RNAs) .a 296 to 873 1 to 582       582/812
(71 %)
13 diff
(98.4 %id)
BE891642 melanotic melanoma, skin .a 297 to 873 1 to 582       585/746
(78 %)
24 diff
(96.8 %id)
BQ948559 sciatic nerve .a 305 to 873 24 to 597       577/937
(61 %)
31 diff
(96.7 %id)
TI_151774841   .a 305 to 834 104 to 632       529/807
(65 %)
41 diff
(95.0 %id)
CN431768 embryonic stem cells, cell lines H1, H7, andH9 .a 307 to 595 1 to 289       289/289
(100 %)
0 diff
(100 %id)
BU527026 epidermoid carcinoma, cell line, lung .a 311 to 864 32 to 588       560/1085
(51 %)
24 diff
(97.8 %id)
BG488812 large cell carcinoma, lung .a 313 to 967 1 to 656       656/671
(97 %)
11 diff
(98.4 %id)
BG830804 epithelioid carcinoma cell line, Pancreas .a 314 to 788 1 to 479       479/677
(70 %)
15 diff
(97.8 %id)
BP421555 small intestine .a 315 to 643 1 to 329     Submitted on the opposite strand 329/329
(100 %)
2 diff
(99.4 %id)
CR746960 leiomyosarcoma, uterus .a 321 to 811 1 to 492       492/492
(100 %)
7 diff
(98.6 %id)
DB501296 hypothalamus .a 321 to 824 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
BM543908 ovary (pool of 3) .a 331 to 873 24 to 565       542/1400
(38 %)
12 diff
(99.2 %id)
CN431767 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 333 to 522 1 to 190       190/190
(100 %)
1 diff
(99.5 %id)
BQ186087 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 336 to 922 1 to 587   tiling clone,   587/587
(100 %)
0 diff
(100 %id)
CN431766 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 388 to 856 10 to 479       470/479
(98 %)
1 diff
(99.8 %id)
BE276991 melanotic melanoma, skin .a 421 to 958 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
AW245240 lung, small cell carcinoma .a 426 to 804 2 to 380   available from MGC,   379/380
(99 %)
5 diff
(98.7 %id)
TI_1948208743   .a 430 to 1162 130 to 861   fully sequenced,   732/861
(85 %)
24 diff
(97.3 %id)
TI_1948208913   .a 430 to 960 128 to 658       531/1433
(37 %)
9 diff
(99.4 %id)
TI_1948209080   .a 430 to 1159 130 to 859   fully sequenced,   730/859
(84 %)
18 diff
(98.0 %id)
TI_1948209249   .a 430 to 807 125 to 502   fully sequenced,   378/502
(75 %)
6 diff
(98.9 %id)
EL734265 mixed .a 432 to 1078 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
AI906014 breast .a 454 to 597 153 to 10       144/168
(85 %)
2 diff
(98.9 %id)
CN431770 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 460 to 823 1 to 364       364/364
(100 %)
1 diff
(99.8 %id)
H56459 pineal gland .a 499 to 836 16 to 361       349/372
(93 %)
25 diff
(93.3 %id)
AW973223   .a 523 to 836 118 to 431       318/431
(73 %)
8 diff
(98.2 %id)
AA886469 metastatic prostate bone lesion .a 584 to 764 1 to 180       180/180
(100 %)
6 diff
(96.7 %id)
BP429860   .a 617 to 958 1 to 342       342/342
(100 %)
3 diff
(99.2 %id)
EC468387 Prostate .a 637 to 750 1 to 110       110/110
(100 %)
5 diff
(95.5 %id)
BI791475 Pancreas, Purified pancreatic islet .a 711 to 909 199 to 1       199/202
(98 %)
8 diff
(96.1 %id)
TI_1948209250   .a 777 to 1159 508 to 125   fully sequenced,   384/508
(75 %)
1 diff
(99.9 %id)
TI_1948208744   .a 843 to 1159 439 to 123   fully sequenced,   317/439
(72 %)
1 diff
(99.8 %id)
TI_1948209081   .a 843 to 1159 439 to 123   fully sequenced,   317/439
(72 %)
1 diff
(99.8 %id)
BU507579 leiomyosarcoma, uterus .b 1 to 831 1 to 840   tiling clone,   840/861
(97 %)
22 diff
(97.5 %id)
EB387670 eye, optic nerve .b 101 to 929 1 to 829       829/829
(100 %)
5 diff
(99.4 %id)
BC019071 Pancreas, epithelioid carcinoma .b 102 to 957 1 to 856   tiling clone, available from MGC, AAA   856/856
(100 %)
1 diff
(99.9 %id)
NM_004765.2   .b 102 to 957 1 to 856   RefSeq, AAA   856/856
(100 %)
0 diff
(100 %id)
BF982945 duodenal adenocarcinoma, cell line, small intestine .b 105 to 850 1 to 753       753/896
(84 %)
37 diff
(95.9 %id)
BM712804 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 110 to 358 9 to 257   fully sequenced,   249/257
(96 %)
6 diff
(97.7 %id)
BQ428253 leiomyosarcoma, uterus .b 114 to 824 10 to 724       715/910
(78 %)
28 diff
(97.0 %id)
BI668566 brain, hypothalamus .b 120 to 805 1 to 686       686/688
(99 %)
6 diff
(99.2 %id)
TI_44344737   .b 125 to 805 91 to 771       681/773
(88 %)
7 diff
(99.1 %id)
BM800675 leiomyosarcoma, uterus .b 129 to 955 9 to 845       837/1058
(79 %)
29 diff
(97.3 %id)
BG760881 melanotic melanoma, high MDR (cell line), skin .b 133 to 944 1 to 810       812/811
(100 %)
26 diff
(96.8 %id)
CR989937 T-Lymphocytes .b 136 to 948 1 to 813       813/814
(99 %)
1 diff
(99.9 %id)
BM806243 leiomyosarcoma, uterus .b 137 to 955 1 to 823       823/1112
(74 %)
12 diff
(99.0 %id)
BU160225 melanotic melanoma, skin .b 140 to 955 1 to 825       825/937
(88 %)
25 diff
(97.4 %id)
BG684506 B-cells, primary B-cells from tonsils (cell line) .b 155 to 959 1 to 793       793/810
(97 %)
16 diff
(98.1 %id)
CA489656   .b 178 to 956 1 to 782       782/897
(87 %)
7 diff
(99.3 %id)
TI_159683675   .b 189 to 959 923 to 155   AAA   769/1108
(69 %)
33 diff
(97.1 %id)
CD518801 White Matter .b 235 to 959 1 to 725       725/730
(99 %)
1 diff
(99.9 %id)
AJ223980 skeletal muscle .b 236 to 957 1 to 722       722/722
(100 %)
2 diff
(99.8 %id)
CV029111 mixed .b 236 to 857 1 to 622       622/624
(99 %)
4 diff
(99.4 %id)
CB243151 Human Lung Epithelial cells, lung .b 281 to 957 693 to 19   AAA   678/678
(100 %)
7 diff
(99.0 %id)
BQ420735 large cell carcinoma, lung .b 288 to 957 1 to 671   AAA   671/671
(100 %)
5 diff
(99.3 %id)
BM676145 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 297 to 957 679 to 19   fully sequenced, AAA   661/661
(100 %)
1 diff
(99.9 %id)
BM793374 Ascites, stomach .b 313 to 884 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
EL947366 eyeball .b 331 to 831 19 to 519       499/519
(96 %)
6 diff
(98.9 %id)
BM790826 stomach .b 337 to 888 1 to 554       554/554
(100 %)
2 diff
(99.7 %id)
BQ212740 melanotic melanoma, skin .b 341 to 957 1 to 617       617/890
(69 %)
3 diff
(99.7 %id)
BQ416737 Pancreas, Purified pancreatic islet .b 350 to 959 612 to 3       610/612
(99 %)
15 diff
(97.6 %id)
AI828526 anaplastic oligodendroglioma, brain .b 351 to 954 604 to 1       604/605
(99 %)
23 diff
(96.2 %id)
BQ181046 Knee, Osteoarthritic Cartilage .b 375 to 957 601 to 19   AAA   583/583
(100 %)
0 diff
(100 %id)
BM682538 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 394 to 957 582 to 19   AAA   564/564
(100 %)
3 diff
(99.5 %id)
AI499423 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 405 to 959 559 to 6       554/695
(79 %)
5 diff
(99.3 %id)
AI695130 colon .b 405 to 959 552 to 1       552/556
(99 %)
14 diff
(97.5 %id)
AI831406 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 407 to 957 574 to 24   AAA   551/563
(97 %)
35 diff
(93.8 %id)
BU740339 eye, lens .b 407 to 957 569 to 19   AAA   551/551
(100 %)
3 diff
(99.5 %id)
TI_151734000   .b 425 to 957 619 to 87   AAA   533/880
(60 %)
5 diff
(99.5 %id)
BQ189495 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 426 to 957 1 to 533   fully sequenced, AAA   533/533
(100 %)
4 diff
(99.3 %id)
AW082632 colon, moderately differentiated adenocarcinoma .b 434 to 957 525 to 1       525/525
(100 %)
9 diff
(98.3 %id)
BU902606 leiomyosarcoma, uterus .b 450 to 957 1 to 508   AAA   508/508
(100 %)
0 diff
(100 %id)
TI_149294764   .b 461 to 957 596 to 99   AAA   498/928
(53 %)
4 diff
(99.6 %id)
AI280969 adenocarcinoma, colon .b 463 to 958 496 to 1       496/498
(99 %)
11 diff
(97.8 %id)
BU683396 lung .b 467 to 957 509 to 19   AAA   491/497
(98 %)
0 diff
(100 %id)
BF525568 brain, glioblastoma with EGFR amplification .b 468 to 957 1 to 486   AAA   486/486
(100 %)
4 diff
(99.2 %id)
BF525661 brain, glioblastoma with EGFR amplification .b 469 to 957 1 to 491   AAA   491/491
(100 %)
5 diff
(99.0 %id)
BP393957 pancreatic islet .b 470 to 957 1 to 488     Submitted on the opposite strand 488/488
(100 %)
3 diff
(99.4 %id)
DB572491 hypothalamus .b 477 to 957 1 to 481     Submitted on the opposite strand 481/481
(100 %)
1 diff
(99.8 %id)
AI459704 brain, meningioma .b 479 to 884 406 to 1       406/406
(100 %)
8 diff
(98.1 %id)
AI356163 anaplastic oligodendroglioma, brain .b 500 to 957 459 to 1       459/459
(100 %)
18 diff
(96.1 %id)
AW087236 colon, moderately differentiated adenocarcinoma .b 515 to 959 458 to 7       452/495
(91 %)
7 diff
(98.6 %id)
EL952502 eyeball .b 517 to 955 1 to 439       439/439
(100 %)
6 diff
(98.7 %id)
BM874057   .b 523 to 957 451 to 15   AAA   437/438
(99 %)
7 diff
(98.5 %id)
AW024221 Kidney .b 525 to 959 441 to 8       434/441
(98 %)
4 diff
(99.1 %id)
AW615293 colon, moderately-differentiated adenocarcinoma .b 531 to 884 354 to 1       354/364
(97 %)
33 diff
(91.0 %id)
AA723403 heart .b 550 to 957 419 to 15   AAA   405/405
(100 %)
7 diff
(98.3 %id)
AI283787 Kidney .b 554 to 957 446 to 43   AAA   404/407
(99 %)
36 diff
(91.2 %id)
AI597611 anaplastic oligodendroglioma, brain .b 558 to 957 423 to 24   AAA   400/400
(100 %)
10 diff
(97.5 %id)
N25466 melanocyte .b 578 to 957 1 to 375   AAA   375/375
(100 %)
12 diff
(96.8 %id)
AI983961 colon, colonic mucosa from 3 patients with Crohn'sdisease .b 594 to 959 372 to 7       366/382
(95 %)
0 diff
(100 %id)
CN431769 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 597 to 957 1 to 361   AAA   361/361
(100 %)
1 diff
(99.8 %id)
BE882591 leiomyosarcoma, uterus .b 612 to 957 1 to 346   AAA   346/346
(100 %)
3 diff
(99.2 %id)
AI244496 Kidney .b 623 to 958 338 to 1       338/345
(97 %)
4 diff
(98.9 %id)
CK300494 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 647 to 957 330 to 19   fully sequenced, AAA   312/312
(100 %)
3 diff
(99.1 %id)
BM980279 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 650 to 957 326 to 19   AAA   308/308
(100 %)
4 diff
(98.8 %id)
AI474237 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 654 to 957 310 to 1       308/310
(99 %)
12 diff
(96.2 %id)
AA428025 ovarian tumor, ovary .b 675 to 957 1 to 279   AAA   279/279
(100 %)
6 diff
(97.9 %id)
BI033573 nervous_normal .b 676 to 805 11 to 137       130/149
(87 %)
8 diff
(94.7 %id)
AA661849 normal prostate, Prostate .b 714 to 959 249 to 6       244/249
(97 %)
1 diff
(99.6 %id)
BE909360 epithelioid carcinoma, Pancreas .b 740 to 884 151 to 7     Submitted on the opposite strand 145/151
(96 %)
0 diff
(100 %id)
CN482466 eye .b 812 to 959 1 to 148       148/255
(58 %)
1 diff
(99.7 %id)
BC010017 Lung, small cell carcinoma .c 1 to 1590 1 to 1590 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1590/1590
(100 %)
0 diff
(100 %id)
AA112138 muscle, skeletal muscle .c 313 to 686 1 to 386       386/386
(100 %)
16 diff
(95.9 %id)
AW249720 lung, small cell carcinoma .c 1072 to 1600 529 to 1   available from MGC,   529/529
(100 %)
2 diff
(99.7 %id)
AI146266 heart .c 1083 to 1590 508 to 1       508/508
(100 %)
2 diff
(99.7 %id)
AW277135 ovary, papillary serous ovarian metastasis .c 1122 to 1456 40 to 374     Submitted on the opposite strand 335/374
(89 %)
6 diff
(98.4 %id)
AA086232 muscle, skeletal muscle .c 1363 to 1811 460 to 1       460/460
(100 %)
13 diff
(97.2 %id)
AI377560   .c 1407 to 1868 466 to 5   tiling clone,   462/466
(99 %)
0 diff
(100 %id)
BX327431   .c 1577 to 1871 48 to 339   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 292/339
(86 %)
1 diff
(99.8 %id)
BX327430   .c 1577 to 1872 49 to 341   tiling clone,   293/348
(84 %)
2 diff
(99.5 %id)
BU158170 epidermoid carcinoma, cell line, salivary gland .d 1 to 587 13 to 601   tiling clone,   589/981
(60 %)
13 diff
(98.7 %id)
AA476557   .d 140 to 544 1 to 402   tiling clone,   402/402
(100 %)
10 diff
(97.6 %id)
BF364536 nervous_normal .d 377 to 858 501 to 20   tiling clone,   482/501
(96 %)
2 diff
(99.7 %id)
BG014826 placenta_normal .d 461 to 732 62 to 337       276/337
(81 %)
10 diff
(97.1 %id)
BI005994 kidney_tumor .d 519 to 662 145 to 2       144/145
(99 %)
4 diff
(97.3 %id)
BU850184 ovary, teratocarcinoma, cell line .e 1 to 595 1 to 595 exact tiling clone,   595/639
(93 %)
1 diff
(99.9 %id)
AI679652 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 158 to 593 456 to 15   AAA   442/442
(100 %)
18 diff
(96.0 %id)
AA293840   .f-u 1 to 289 1 to 289   tiling clone, fully sequenced,   289/289
(100 %)
2 diff
(99.4 %id)
AA400425   .f-u 6 to 368 1 to 365   tiling clone, fully sequenced,   365/365
(100 %)
11 diff
(97.0 %id)
DB097028 testis .f-u 211 to 702 2 to 493   tiling clone, capped   492/492
(100 %)
0 diff
(100 %id)
AA402441   .f-u 259 to 532 272 to 1   fully sequenced,   272/272
(100 %)
9 diff
(96.7 %id)
AA400426   .f-u 338 to 527 191 to 1   fully sequenced,   191/191
(100 %)
11 diff
(94.3 %id)
DA470114   .g 1 to 551 2 to 553 Q48H S49X S50L R51P R53E ... tiling clone, capped   552/552
(100 %)
1 diff
(99.9 %id)
DB042744 testis .h 1 to 599 2 to 570 exact tiling clone, capped Suspected internal deletion 569/569
(100 %)
0 diff
(100 %id)
DB337972 testis .h 1023 to 1541 519 to 1   tiling clone, Suspected internal deletion 519/519
(100 %)
1 diff
(99.9 %id)
AW340170 pooled .h 1102 to 1543 445 to 4   tiling clone,   442/445
(99 %)
0 diff
(100 %id)
CN284787 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 1332 to 1918 1 to 587   tiling clone,   587/587
(100 %)
0 diff
(100 %id)
BG055884 anaplastic oligodendroglioma, brain .h 1391 to 1543 157 to 5       153/157
(97 %)
0 diff
(100 %id)
BX493547   .h 1616 to 1958 1 to 343   tiling clone,   343/343
(100 %)
1 diff
(99.8 %id)
BQ368513 placenta_normal Gene BCL7C, variant not shown         This clone was ignored    
BE559984 Burkitt lymphoma, lymph Gene BCL7C, variant not shown         Suspected internal deletion, this clone was ignored    
BI225491 Burkitt lymphoma, lymph Gene BCL7C, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BQ269232 Pancreas, Purified pancreatic islet Gene BCL7C, variant not shown         Suspected internal deletion, this clone was ignored    
CK825699 Pancreas, Purified pancreatic islet Gene BCL7C, variant not shown         Submitted on the opposite strand, submitted on the opposite strand, submitted on the opposite strand    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C